top of page
Lowering Health Care Costs and Improving Overall Outcomes Cannot Come at a Cost to Patient Access
February 25, 2026 (WASHINGTON, D.C.) — The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the State of the Union address, during which President Trump supported codifying “Most Favored Nation” (MFN) drug pricing: “The 194 million Americans living with multiple chronic conditions depend on consistent, timely access to the therapies that help manage their health. Ensuring these treatments are affordable is a goal PFCD strongly suppo
1 day ago
PFCD Celebrates Passage of PBM Reforms Critical to Lowering Costs and Improving Outcomes for Americans with Chronic Disease
February 4, 2026 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) applauds the passage of the Consolidated Appropriations Act of 2026 and its inclusion of many important health care elements that support efforts to better prevent and manage costly chronic conditions. Notably, the bill will increase transparency and lower health care costs for people living with one or more chronic conditions by instituting much needed reforms for pharmacy benefit managers (
Feb 3
Medicare Drug Pricing Must Not Create New Barriers for People Living with Chronic Disease
January 28, 2026 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the Centers for Medicare & Medicaid Services (CMS) announcement of 15 new drugs selected for price-setting in Initial Price Applicability Year (IPAY) 2028: “Prescription medicines are a cornerstone of chronic disease management for Medicare beneficiaries, the vast majority of whom rely on one or more medications every month to maintain their hea
Jan 27
Chronic Disease is Straining U.S. Health Care, and Insurers Aren’t Helping
Chronic conditions are the primary driver of rising U.S. health care spending across Medicare, Medicaid and private insurance, a new study from the Partnership to Fight Chronic Disease (PFCD) detailed last week. Costs are highly concentrated among patients living with three or more chronic conditions, and obesity plays a central role . PFCD Chair Kenneth Thorpe, PhD., and Peter Joski authored the new research report , which is particularly relevant leading up to two House hea
Jan 21
New Analysis Links Obesity and Multiple Chronic Conditions to Unsustainable Spending Growth Across Insurance Programs
January 14, 2026 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released a new research report, “ The Association of Obesity and Chronic Conditions Treated as it Relates to the Growth in Health Care Spending by Source of Insurance, 2011–2022 ,” by PFCD Chair Kenneth E. Thorpe and Peter J. Joski. The report finds that the increasing prevalence of obesity and multiple chronic conditions is the dominant force behind rising health care spending across M
Jan 14
bottom of page
